Apyx Medical (APYX) Change in Accured Expenses (2011 - 2026)

Apyx Medical has reported Change in Accured Expenses for 16 years, with the latest figure at -$1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 105.49% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$694000.0 (up 55.23% YoY), and the FY2025 full-year result was $209000.0, up 109.22% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.8 million, down from $553000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.4 million in Q4 2023, with the low at -$2.0 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged -$279352.9 across 5 years, with a median of $67000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 5841.67% — and 2025, when it surged 546.39%.
• Apyx Medical's Change in Accured Expenses stood at $328000.0 in 2022, then surged by 335.67% to $1.4 million in 2023, then tumbled by 93.84% to $88000.0 in 2024, then jumped by 528.41% to $553000.0 in 2025, then tumbled by 418.08% to -$1.8 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.8 million (Q1 2026), $553000.0 (Q4 2025), and $79000.0 (Q3 2025), per Business Quant data.